BRD2 Antikörper (Middle Region)
-
- Target Alle BRD2 Antikörper anzeigen
- BRD2 (Bromodomain Containing 2 (BRD2))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to BRD2.
- Aufreinigung
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the center region of human BRD2.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product BRD2 Primärantikörper
-
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibody
BRD2 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 7C1B10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 167-256) antibodyBRD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-100) antibodyBRD2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 170-200) antibodyBRD2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB3416 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibodyBRD2 Reaktivität: Human ELISA Wirt: Maus Monoclonal 1H6B12 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human IP Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (C-Term) antibodyBRD2 Reaktivität: Human, Hamster WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (Internal Region) antibodyBRD2 Reaktivität: Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Immunohistochemistry: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
- Target
- BRD2 (Bromodomain Containing 2 (BRD2))
- Andere Bezeichnung
- BRD2 (BRD2 Produkte)
- Hintergrund
- BRD2 is a mitogen-activated kinase which localizes to the nucleus. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3 but sequence comparison suggests that the protein is not involved in the immune response. Homology to the Drosophila gene female sterile homeotic suggests that this human protein may be part of a signal transduction pathway involved in growth control.Synonyms: Bromodomain-containing protein 2, KIAA9001, O27.1.1, RING3
- Gen-ID
- 6046, 9606
- UniProt
- P25440
- Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-
